Digital Cognitive Assessments
✅ ALZHEIMER'S TESTING—$0 Down. Zero Risk.
Digital Cognitive Assessments
Diabetes Testing Centers™ (DTC) multispecialty Cognitive Assessments platform leverages digital devices to streamline test administration and offer robust clinical insights. Our self-administered test takes 3-minutes or longer to complete, evaluating five domains of brain function. It provides age and gender specific normal ranges and tracks longitudinal results for ongoing monitoring, offering a comprehensive tool for cognitive health assessment.
Patients can conveniently use their smartphones, tablets, or computers to complete assessments both on-site and remotely.
Up to 80% of People with Alzheimer's Have Type 2 Diabetes
At Diabetes Testing Centers™ (DTC), we help medical providers expand beyond standard diabetes care by integrating cognitive assessments into everyday practice. While glucose testing identifies current metabolic status, it does not reveal the silent cognitive decline that affects up to 40% of diabetic patients, and is often missed in primary care.
Our Digital Cognitive Assessment (DCA) is a turnkey solution that enables your existing medical assistants or technicians to administer a clinically validated cognitive screening in just minutes at the point of care. The results are immediately available to the provider for review with the patient, streamlining documentation and improving clinical decision-making—all within a standard office visit.
Built for primary care and multispecialty settings, our cloud-based platform delivers these assessments without the need for additional staff, equipment training, or major workflow changes. With rising awareness of the link between diabetes and cognitive impairment, offering cognitive screening positions your practice as both progressive and preventive, while supporting improved patient outcomes and increased revenue through established CPT reimbursements.
Let me know if you want a version that focuses on Medicare Annual Wellness Visit integration or cognitive decline as an early indicator for broader chronic care pathways.
Our Digital Cognitive Assessment (DCA) measures how well a patient's brain is functioning—specifically in areas like thinking, learning, and memory.
Why Cognitive Assessments Matter in Chronic Care
Cognitive decline often goes undetected in patients with chronic conditions. Diabetes Testing Centers™ (DTC) offers turnkey cognitive assessments that help providers identify risks early, improving outcomes and supporting reimbursable care. Below are key conditions where cognitive screening is clinically justified:
Diabetes: Up to 80% of Alzheimer's patients have Type 2 diabetes or insulin resistance.
Action: Screen annually for "Type 3 diabetes" risk.
Neuropathy: Cognitive dysfunction affects up to 40% of patients with diabetic neuropathy.
Action: Include cognition in neuropathy evaluations.
Depression: Late-life depression doubles dementia risk and impairs memory and focus.
Action: Screen depressed patients, especially over 60.
Cardiovascular Disease: CVD increases dementia risk by up to 50% due to vascular brain damage.
Action: Assess cognition in patients with heart failure, hypertension, or AFib.
Hypertension: Midlife hypertension raises dementia risk by 60%.
Action: Screen older adults with long-term high blood pressure.
Chronic Kidney Disease: Cognitive impairment is found in 70% of dialysis patients.
Action: Consider screening in moderate to advanced CKD.
Clinical Takeaway: If you're treating these conditions, cognitive decline is likely present. DTC makes it easy to assess, right at the point of care.
Poorly Controlled Blood Sugar Increase the Risk of Developing Alzheimer's
Cognitive Assessments: A Critical Tool Across Medical Disciplines
Cognitive assessments are essential for evaluating brain function and identifying early signs of cognitive decline. While primary care providers (PCPs) often lead initial screenings, cognitive testing plays a key role across multiple specialties. These assessments not only help detect and manage conditions like dementia and memory loss but also inform clinical decisions in a wide range of patient populations—ultimately improving outcomes and care coordination.
Below is an alphabetical overview of healthcare providers who routinely incorporate cognitive assessments into their clinical workflows:
Audiologists: Evaluate the impact of hearing loss on cognitive performance and screen for decline.
Cardiologists: Monitor cognitive function in patients with vascular risk factors, heart failure, or atrial fibrillation.
Geriatricians: Routinely assess older adults to manage age-related cognitive impairment and prevent functional decline.
Neurologists: Diagnose and manage neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and vascular dementia.
Neurosurgeons: Assess cognitive status pre- and post-operatively to ensure safety and guide recovery.
Occupational Therapists: Evaluate cognitive skills necessary for daily tasks and develop personalized rehabilitation plans.
Oncologists: Identify cognitive changes in patients undergoing chemotherapy (e.g., “chemo brain”) and guide supportive care.
Pediatricians: Monitor developmental milestones and cognitive health in children to detect early delays or conditions like ADHD.
Pharmacists: Flag medications or interactions that may impair cognition, especially in polypharmacy or geriatric patients.
Primary Care Providers: Screen during routine exams or Medicare Wellness Visits to catch early cognitive changes.
Psychiatrists: Evaluate cognitive function as part of diagnosing and managing mood disorders, psychosis, and treatment effects.
Psychologists/Neuropsychologists: Conduct in-depth cognitive testing to diagnose learning disabilities, brain injuries, and cognitive disorders.
Rehabilitation Specialists (PM&R): Use assessments to guide therapy for stroke, traumatic brain injury, or neurological rehab.
This diverse clinical use underscores the vital importance of cognitive health across the healthcare spectrum—reinforcing why assessments should be part of routine care, particularly for at-risk populations like those with diabetes, cardiovascular disease, or advanced age.
Alzheimer's is Underdiagnosed & Undertreated